Antibodies against annexin A2 in antiphospholipid syndrome, together with inhibition of plasmin release, promote thrombus formation [39]; of note, 20% of CTEPH patients carry antiphospholipid antibodies [4]. This evidence concerns the gene ANXA2 and chronic thromboembolic pulmonary hypertension.